AI assistant
ABBOTT LABORATORIES — Director's Dealing 2014
Feb 25, 2014
29777_dirs_2014-02-25_ac952c88-0956-40f0-b72f-9c26bbb54c3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-21
Reporting Person: Contreras Jaime (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-21 | Common shares without par value | A | 18403 | — | Acquired | 42136 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-21 | Option(right to buy) | $39.12 | A | 112668 | Acquired | 2024-02-20 | Common shares (112668) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 20 | Indirect |
| Common shares without par value | 16 | Indirect |
| Common shares without par value | 63903 | Indirect |
| Common shares without par value | 1067 | Indirect |
| Common shares without par value | 12081 | Indirect |
Footnotes
F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2014.
F3: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
F4: The reporting person disclaims beneficial ownership of all securities held by his spouse.
F5: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
F6: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,556 on 2/21/2015, 37,556 on 2/21/2016, and 37,556 on 2/21/2017.